DEBRA PETERSON: Open Payments
NPI 1285725895 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 72 payments from 21 companies in 2025. Trend: 2023 $173 · 2024 $1,356 · 2025 $1,544
Food & beverage: $1,544
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $412 |
| AstraZeneca Pharmaceuticals LP | 6 | $256 |
| PFIZER INC. | 10 | $153 |
| Amgen Inc. | 7 | $152 |
| Dexcom, Inc. | 3 | $66 |
| Daiichi Sankyo Inc. | 2 | $53 |
| Aimmune Therapeutics, Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Astellas Pharma US Inc | 2 | $44 |
| Lilly USA, LLC | 2 | $43 |
Products named: VRAYLAR, BREZTRI, AIRSUPRA, UBRELVY, EVENITY, Dexcom G6 Transmitter, LINZESS, INJECTAFER.
Industry payments across CA — which companies pay providers there.
